Graph Therapeutics
Austria - KlosterneuburgBiotechnology
Focus: Graph Therapeutics is an AI-driven drug discovery platform company based in Austria focused on leveraging computational approaches to identify and develop novel therapeutics. The company operates as a public-stage biotech firm specializing in platform technology rather than a traditional pipeline-driven model.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
3+3 this month
Stable — net +3 jobs in 30d
3 added, 0 removed. Backfill posture.
Should You Work at Graph Therapeutics?
AI assessmentBest suited for computational scientists and platform engineers seeking early-stage biotech experience; clinical and commercial professionals should assess pipeline maturity before committing.
Why Work Here
- Opportunity to work at the intersection of AI/machine learning and drug discovery during a period of significant industry transformation toward computational biology
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Graph Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.